|
⚲
|
| Keyboard |
| Foy Matthew
✚
|
|
|---|---|
| CIK # | 0001842129 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001842129] | |
| 4 | [0001842129] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Decibel Therapeutics Inc | |
| Foy Matthew |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Decibel Therapeutics Inc DBTX
Series D Preferred Stock · derivative
|
2021-02-17 | Conversion | 1,737,619 | $0.00 | |
|
Decibel Therapeutics Inc DBTX
Common Stock
|
2021-02-17 | Conversion | 458,487 | ||
|
Decibel Therapeutics Inc DBTX
Common Stock
|
2021-02-17 | Conversion | 247,324 | ||
|
Decibel Therapeutics Inc DBTX
Common Stock
|
2021-02-17 | Conversion | 327,852 | ||
|
Decibel Therapeutics Inc DBTX
Common Stock
|
2021-02-17 | Buy | 150,000 | $18.00 | 2,700,000 |
|
Decibel Therapeutics Inc DBTX
Series C Preferred Stock · derivative
|
2021-02-17 | Conversion | 3,125,000 | $0.00 | |
|
Decibel Therapeutics Inc DBTX
Series A Preferred Stock · derivative
|
2021-02-17 | Conversion | 7,119,852 | $0.00 | |
|
Decibel Therapeutics Inc DBTX
Stock Option (right to buy) · derivative
|
2021-02-11 | Grant | 20,000 | $0.00 |